<DOC>
	<DOCNO>NCT02158845</DOCNO>
	<brief_summary>The hemostatic inflammatory system may activate . Endometriosis chronic inflammatory disease affect 10 % woman . The objective study compare hemostatic effect two treatment widely prescribe woman endometriosis : levonorgestrel intrauterine system ( LNG-IUS ) gonadotropin-releasing hormone analog ( GnRHa ) leuprolide acetate . Hypothesis : H0 : There alteration hemostatic system use GnRHa LNG-IUS H1 : There alteration hemostatic system use GnRHa LNG-IUS</brief_summary>
	<brief_title>Levonorgestrel-releasing Intrauterine System Patients With Endometriosis</brief_title>
	<detailed_description>Materials Methods : In randomize open-label control trial , 44 woman endometriosis randomly allocate one two group : 22 woman assign use LNG-IUS 22 use GnRHa . The assessed variable D-dimers , fibrinogen , prothrombin time , activate partial thromboplastin time , coagulation factor ( F ) II , V , VII , VIII , IX , X , XI , antithrombin ( AT ) , protein C , free protein S , tissue plasminogen activator ( t-PA ) , α2-antiplasmin , thrombin-antithrombin complex , prothrombin fragment 1+2 . All variable assess treatment six month treatment onset .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>endometriosis age 18 40 year Being without contraceptive least 3 month depot medroxyprogesterone acetate GnRHa least 6 month time randomization . obese patient body mass index ( BMI ) ≥30 kg/m2 smoker diabetic alcohol drug user patient currently wish conceive patient chronic disease ( except endometriosis ) patient infectious process patient personal and/or family history thromboembolic event patient take medication know interfere inflammation marker ( hormonal nonhormonal antiinflammatory agent ) within 15 day study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>endometriosis</keyword>
	<keyword>blood coagulation</keyword>
	<keyword>levonorgestrel</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>progesterone-releasing intrauterine device</keyword>
</DOC>